Filter by:
Continuous Improvement
A pharmaceutical manufacturing innovation that came out of a Virginia university is changing the way medicines are made. The Commonwealth’s universities and the rest of its biopharma research community are making sure Virginia is ready to make the medicines of the future.
Enabling Innovation
Would more men try to prevent unintended pregnancies if their choices for contraception went beyond a condom or vasectomy?
Behind the Effort to Bring Drug Manufacturing Back to U.S. Shores
In October 2025, shovels went into the ground in Elkton, marking the start of a $3 billion pharmaceutical expansion project that will add 400,000 square feet to Merck’s existing campus.
Dulles Prepares for Pharma Growth Through Brussels Partnership
Recent major biopharmaceutical announcements have sent a clear signal from the industry: Virginia is the future of biopharma manufacturing.
Richmond
The Communities at the Forefront of Virginia’s Biopharma Push: Greater Richmond
The Greater Richmond region is in the middle of the greatest population growth in its history.
Hopewell Riverwalk
The Communities at the Forefront of Virginia’s Biopharma Push: The I95-I85 Intersection
The I95-I85 Intersection is anchored by the Tri-Cities of Petersburg (home to Civica Rx’s facility that produces a wide variety of affordable essential medicines), Hopewell, and Colonial Heights.
The Urgency of Building Healthier Communities
Pam Cheng is executive vice president of global operations and IT and chief sustainability officer at AstraZeneca, which recently announced a new facility in Albemarle County — the company’s first in Virginia.
